Thursday, 21 March 2019

Biogen halts study of Alzheimer’s drug, once pinned as “the last great hope for AD”. At this point, 4 Anti-Aβ mAbs have failed 9 big Ph3 trials, 3 γ-Secretase inhibitors showed cognitive worsening, 4 BACE inhibitors showed cognitive worsening. Global pipeline for AD looks bleak.


Biogen halts study of Alzheimer’s drug, once pinned as “the last great hope for AD”. At this point, 4 Anti-Aβ mAbs have failed 9 big Ph3 trials, 3 γ-Secretase inhibitors showed cognitive worsening, 4 BACE inhibitors showed cognitive worsening. Global pipeline for AD looks bleak.: https://ift.tt/2HAjSrD Read more... https://ift.tt/2FrgrRU

No comments:

Post a Comment